SKINVIVE™ by JUVÉDERM® Safety Information

SKINVIVE™ is from the world’s #1 brand of hyaluronic acid facial fillers1,* and has undergone extensive clinical testing.2–6

To determine if SKINVIVE™ by JUVÉDERM® is right for you, your healthcare professional will ask about your medical history.

SKINVIVE™ by JUVÉDERM® is not suitable for you if:7

  • You have untreated epilepsy
  • You tend to develop hypertrophic scarring
  • You have allergies to hyaluronic acid or other filler products, or allergies to lidocaine or other local anaesthetics
  • You have a history of porphyria
  • You are pregnant or breastfeeding
  • You are under the age of 18 years

Make sure you tell your healthcare practitioner if:7

  • You have skin infections or inflammation such as acne or cold sores (as SKINVIVE™ by JUVÉDERM® must not be used in these areas)
  • You have recently had other skin surface treatments (such as laser treatment, skin peels or dermabrasion) or have previously used fillers
  • You have a history of autoimmune disease, autoimmune deficiency or being under immunosuppressive therapy
  • You have a history of severe and/or multiple allergies
  • You have a history of streptococcal disease (recurrent sore throats, acute rheumatic fever)
  • You are currently taking medications which prolong bleeding, such as acetylsalicylic acid (aspirin), non-steroidal anti-inflammatory drugs or anticoagulants

 

Please note that this is not an exhaustive list of what to discuss with your practitioner.

Like all medical procedures, treatments with SKINVIVE™ by JUVÉDERM® may cause side effects.7 To minimise the risk of potential side effects, SKINVIVE™ by JUVÉDERM® should only be administered by medical practitioners who have appropriate training and experience in injection techniques, and who are knowledgeable about the anatomy in and around the injection site.

Potential side effects associated with SKINVIVE™ by JUVÉDERM® include temporary injection-site reactions such as redness, swelling, itching, pain, firmness, bumps, bruising, and discolouration. These reactions may occur immediately or may be delayed. As with any injection, there is a risk of infection. This is not a complete list of potential side effects. If inflammatory reactions persist for more than one week, or if any other side effects develop, seek medical attention as soon as possible.Please refer to SKINVIVE by JUVÉDERM® Directions for use (DFU) for a full list of indications, contraindications, precautions for use, and adverse events.

Footnotes

  • *Based on HCP tracking market research involving over 1,700 HCPs from 16 international markets.1

References

  1. Allergan Aesthetics. Data on file. Juvéderm®, the world’s leading brand of hyaluronic acid facial fillers claim. REF-108642. March 2023.
  2. Allergan Aesthetics. Data on File. Juvéderm® Manufacturing and Quality Controls. REF-114344. September 2023.
  3. Niforos F et al. Clin Cosmet Investig Dermatol. 2019;12:791–798.
  4. Alexiades M et al. Dermatol Surg. 2023;49(7):682–688.
  5. Ogilvie P et al. J Cosmet Dermatol. 2020;19(5):1065–1070.
  6. Safa M et al. Clin Cosmet Investig Dermatol. 2022;15:411–426.
  7. SKINVIVE™ by JUVÉDERM®  DFU. 20081699. Revision 2023-10-04.

The information on this website is intended for informational and educational purposes only and should not be used as a substitute for advice provided by a qualified aesthetic healthcare professional.

Website produced and funded by Allergan Aesthetics, an AbbVie company.

Models received a variety of JUVÉDERM® products, including SKINVIVE™ by JUVÉDERM®. Images provided courtesy of Allergan Aesthetics, an AbbVie company (unless stated otherwise). Actual treatment results may vary. Images are for illustrative purposes only.

IMPORTANT SAFETY INFORMATION

This content is intended for UK and Irish adult (>18yrs) audiences only. You should always consult a healthcare professional to help you decide if SKINVIVE™ by JUVÉDERM® is right for you and provide you with a full list of potential side effects.

Potential side effects associated with SKINVIVE™ by JUVÉDERM® include temporary injection-site reactions such as redness, swelling, itching, pain, firmness, bumps, bruising, and discolouration. These reactions may occur immediately or may be delayed. As with any injection, there is a risk of infection. This is not a complete list of side effects. If inflammatory reactions persist for more than one week, or if any other side effects develop, seek medical attention as soon as possible.7

Please refer to SKINVIVE by JUVÉDERM® Directions for use (DFU) for a full list of indications, contraindications, precautions for use, and adverse events.

Adverse events should be reported. 

 

Reporting of side effects:

UK patients: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can help by reporting side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores. Adverse events should also be reported to AbbVie at ProductSurveillance_EAME@allergan.com. By reporting side effects, you can help provide more information on the safety of this product.

 

Irish patients: If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via www.hpra.ie.